A Phase I Study of the Effect of Exercise on Cancer


Full Title

Phase 1a/b Trial of Exercise as Interception Therapy for Primary High-Risk Cancer


Researchers think that exercise may be able to prevent cancer from coming back by changing circulating levels of various factors in a person’s body, as measured in the blood. In this study, they are exploring how aerobic exercise may favorably change circulating levels of these factors to prevent or slow the return of cancer. During the study, they will try to find the highest level of exercise that is practical, is safe, and has positive effects on the body by preventing or slowing the return of cancer in people who were previously treated for colorectal or breast cancer.

Participants in this study will engage in walking sessions three to six times a week for a total of 90-375 minutes each week. They will participate in these walking sessions for up to 18 months. The walking sessions will be on a treadmill sent to their homes.

Who Can Join

To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • Participants must have completed treatment for breast or colorectal cancer within the last 1-12 months and have no evidence of disease.
  • They should be exercising less than 50 minutes per week upon entering the study.
  • People who have another current cancer diagnosis may not participate.
  • This study is for people age 18 and older.

For more information about this study and to ask about eligibility, please contact the office of Dr. Lee Jones at 646-888-8103.




Phase I (phase 1)


Luis Diaz

ClinicalTrials.gov ID